Darling Ingredients' Health Brand Rousselot Receives U.S. Patent For Gelatin Technology That Improves Soft Gel Capsule Stability And Efficacy
Portfolio Pulse from Benzinga Newsdesk
Darling Ingredients Inc. (NYSE:DAR) announced that its health brand Rousselot received a U.S. patent for StabiCaps, a gelatin technology enhancing soft gel capsules' stability and efficacy. StabiCaps prevents crosslinking issues, ensuring better release of active ingredients. The technology, which also holds a European patent, is part of Rousselot's portfolio aimed at the nutra- and pharmaceutical markets. The global soft gel capsules market is expected to grow at a 4.3% CAGR from 2023 to 2033.
December 04, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Darling Ingredients Inc. secures a U.S. patent for StabiCaps technology through its brand Rousselot, which could enhance its product offering in the nutra- and pharmaceutical sectors.
The granting of the U.S. patent for StabiCaps technology is likely to provide Darling Ingredients with a competitive advantage in the soft gel capsule market, which is projected to grow steadily. This patent can lead to potential new business and partnerships, enhancing the company's product portfolio and possibly its financial performance in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90